Whitehawk Therapeutics (WHWK) Change in Inventory (2022 - 2025)
Whitehawk Therapeutics (WHWK) reported Change in Inventory of -$170000.0 for Q1 2025, up 65.31% year-over-year from -$102839.5 in Q1 2024, and down 7.59% quarter-over-quarter from -$158000.0 in Q4 2024.
Whitehawk Therapeutics (WHWK) Change in Inventory (2022 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 4 years of Change in Inventory data on file, last reported at -$170000.0 in Q1 2025.
- Change in Inventory for Q1 2025 came in at -$170000.0, up 65.31% year-over-year; the trailing twelve-month figure through Dec 2025 was -$170000.0 (up 84.77% YoY), and the FY2025 annual result was -$170000.0, up 84.77% from the prior year.
- Change in Inventory slipped to -$170000.0 in Q1 2025 per WHWK's latest filing, from -$158000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $2.2 million in Q4 2023 and troughed at -$630000.0 in Q3 2024.
- A 4-year average of $295384.6 and a median of $7000.0 in 2022 frame the typical range for Change in Inventory.
- On a YoY basis, Change in Inventory climbed as much as 861.39% in 2023 and fell as far as 4700.0% in 2023.
- A 4-year view of Change in Inventory shows it stood at $1.1 million in 2022, then surged by 97.43% to $2.2 million in 2023, then plunged by 107.1% to -$158000.0 in 2024, then dropped by 7.59% to -$170000.0 in 2025.
- Business Quant data shows WHWK's Change in Inventory at -$170000.0 in Q1 2025, -$158000.0 in Q4 2024, and -$630000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -170,000.00 |
| Mar 31, 2025 | -170,000.00 |
| Dec 31, 2024 | -158,000.00 |
| Dec 31, 2024 | -158,000.00 |
| Sep 30, 2024 | -630,000.00 |
| Sep 30, 2024 | -630,000.00 |
| Jun 30, 2024 | 162,000.00 |
| Jun 30, 2024 | 162,000.00 |
| Mar 31, 2024 | -490,000.00 |
| Mar 31, 2024 | -490,000.00 |
| Dec 31, 2023 | 2.23 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Sep 30, 2023 | -322,000.00 |
| Sep 30, 2023 | -322,000.00 |
| Jun 30, 2023 | -580,000.00 |
| Jun 30, 2023 | -580,000.00 |
| Mar 31, 2023 | 1.94 Mn |
| Mar 31, 2023 | 1.94 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Dec 31, 2022 | 1.13 Mn |